We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App





Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients

By HospiMedica International staff writers
Posted on 19 Jul 2022
Print article
Image: High blood viscosity can predict higher risk of death in hospitalized COVID-19 patients (Photo courtesy of Pexels)
Image: High blood viscosity can predict higher risk of death in hospitalized COVID-19 patients (Photo courtesy of Pexels)

Doctors typically measure hematocrit and globulins (difference between total protein and albumin) in all patients for diagnosis and monitoring treatment of hospitalized COVID-19 patients; however, they do not measure blood viscosity directly. A validated estimate of blood viscosity can be derived from the hematocrit and globulins. Now, a new study has found that the estimate of blood viscosity was more strongly associated with mortality in COVID-19 patients than other commonly used risk stratification measures. This is an easy calculation that could be added to electronic medical records or lab forms and can improve chances for survival in hospitalized COVID-19 patients.

The large-scale study by researchers at the Icahn School of Medicine at Mount Sinai (New York, NY, USA) is the first to evaluate blood viscosity in the prediction of mortality in COVID-19 patients. The researchers looked at records of 5,621 COVID-19 patients from six hospitals in the Mount Sinai Health System between February 27, 2020, and November 27, 2021. All had clinical and laboratory-verified diagnoses of COVID 19 and were identified within 48 hours of hospitalization and followed until hospital discharge or death. The study found that hospitalized patients who had high blood viscosity had a 60% higher death rate with blood viscosity measured under high flow conditions such as the arteries and 32% higher mortality with blood viscosity measured at low flow such as the microcirculation (blood circulation in the smallest vessels), than patients with a low blood viscosity.

Blood viscosity is elevated by acute phase reactants (fibrinogen, macroglobulins) that have been associated with acute COVID-19 infections. Blood viscosity is an integrated measure of these acute phase reactants and the cellular components that can increase during infection. When the blood viscosity is high, physicians may consider therapeutic heparin for patients, hydration, or intensification of glucocorticoids to lessen the severity of the acute phase response to COVID-19. The study concluded that that a simple calculation of blood viscosity was more robust in the identification of hospitalized patients at risk for dying from COVID-19 complications when compared to common measures of inflammation and the blood clotting biomarker D-dimer.

“This study demonstrates the importance of checking for blood viscosity in COVID-19 patients early in hospital admission, which is easily obtained through routine lab work. Results can help determine the best treatment course for at-risk patients and help improve outcomes,” said Robert Rosenson, MD, Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai. “We are currently investigating the effects of therapeutic heparin to reduce the risk of complications during acute COVID-19 infections, which may greatly benefit those with high blood viscosity.”

Related Links:
Icahn School of Medicine at Mount Sinai 

BMP Whole Blood Analyzer: GEM Premier ChemSTAT
Gold Supplier
Hematology Workflow Solution
DIFF-Line
New
Gold Supplier
Group A Streptococcus Antigen Test
OSOM Strep A Test
New
D-Dimer Test
Epithod 616 D-Dimer Kit

Print article
Radcal

Channels

AI

view channel
Image: AI transforms smartwatch ECG signals into a diagnostic tool for heart failure (Photo courtesy of Pexels)

AI-Based Smartwatch Accurately Detects Heart Failure Using ECG Signals

People with a weak heart pump might not have symptoms, but this common form of heart disease affects about 2% of the population and 9% of people over 60. When the heart cannot pump enough oxygen-rich blood,... Read more

Critical Care

view channel
Image: The genetically engineered FcMBL protein can capture more than 100 different microbial species (Photo courtesy of Wyss Institute)

Rapid Pathogen Capture Technology Could Accelerate Diagnosis of Bloodstream Infections and Sepsis

Bloodstream infections (BSIs) with various microbial pathogens can rapidly escalate to life-threatening sepsis when the body is overwhelmed by the multiplying invaders and shuts down its organs’ functions.... Read more

Surgical Techniques

view channel
Image: CystoSmart image enhancement and AI diagnostic tool will enhance cancer detection (Photo courtesy of Claritas HealthTech)

AI Diagnostic Tool Improves Cancer Detection in Cystoscope Images of Bladder

Bladder cancer is the 10th commonest cancer worldwide and the 6th commonest cancer amongst men. It is known to have high recurrence rates and significant risks of disease progression. Early detection of... Read more

Patient Care

view channel
Image: Automated cleaning system allows endoscopes to be cleaned direct from clinic (Photo courtesy of Aston University)

World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance

Endoscopes are long, thin tubes with a light and camera at one end. Due to the sensitivity of the materials and electronics they cannot be sterilized in an autoclave (a machine that uses steam under pressure),... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Business

view channel
Image: The global multiparameter patient monitoring systems market is expected to surpass USD 15 billion by 2028 (Photo courtesy of Unsplash)

Global Multiparameter Patient Monitoring Systems Market Driven by Rising Chronic Illnesses

Multi-parameter patient monitoring equipment is used to assess the vital signs of patients who are suffering from a serious illness. These devices are meant to give the number of data sets on one screen... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.